The ASCO annual meeting in Chicago last year showcased a clinical trial conducted in China, which is set to be a key presentation again this year. This highlights the growing prominence of China's role in drug development.
Our neutral summary
The ASCO annual meeting in Chicago last year showcased a clinical trial conducted in China, which is set to be a key presentation again this year. This highlights the growing prominence of China's role in drug development.
The reporting belongs to New York Times — Business; we don't reproduce it.
No note attached
on this article.
China’s Rise in Drug Development Looms Over U.S.
China's Drug Development Gains Attention at ASCO Annual Meeting